(Q35563294)

8 August 2017

1 reference

title

Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives (English)

1 reference

8 August 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14567035

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00036-X

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00036-X

22 March 2024

1

Bruno Chauffert

0 references

author name string

Patrick Favoulet

2

1 reference

8 August 2017

Emmanuel Polycarpe

3

1 reference

8 August 2017

Christian Duvillard

4

1 reference

8 August 2017

Jean-Luc Beltramo

5

1 reference

8 August 2017

Francis Bichat

6

1 reference

8 August 2017

Patrick Rat

7

1 reference

8 August 2017

Philippe Genne

8

1 reference

8 August 2017

Laurent Benoit

9

1 reference

8 August 2017

language of work or name

1 reference

1 July 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S105532070300036X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00036-X

https://api.elsevier.com/content/article/PII:S105532070300036X?httpAccept=text/plain

22 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00036-X

Surgical oncology clinics of North America

22 March 2024

published in

1 reference

8 August 2017

volume

12

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

835-848

1 reference

Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Intraperitoneal chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Pharmacology of Intraperitoneal Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Peritoneal-plasma barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Intratumoral infusion of fluid: estimation of hydraulic conductivity and implications for the delivery of therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900036-X

7 January 2021

Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy

7

1 reference

https://api.crossref.org/works/10.1016/S1055-3207(03)00036-X

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference